EUROIMMUN Medizinische Labordiagnostika

What EUROIMMUN Medizinische Labordiagnostika does

EUROIMMUN Medizinische Labordiagnostika AG is a German specialty in-vitro diagnostics company headquartered in Lübeck, founded in 1987 and operating today as a wholly-owned subsidiary of Revvity, Inc. (NYSE: RVTY) since Revvity's 2023 acquisition of PerkinElmer. The company designs, manufactures, and sells medical laboratory diagnostic test systems and automation instruments across seven clinical categories: autoimmunity, infectious diseases, allergy, endocrinology, bone metabolism, neurodegeneration, and therapeutic drug monitoring. Its portfolio spans six core detection technologies — indirect immunofluorescence (IIFT), ELISA, chemiluminescence immunoassay (ChLIA, via the IDS platform), immunoblot, microarray (EUROArray on proprietary BIOCHIPs), and real-time PCR — supported by automation instruments including the UNIQO 160 all-in-one IIFT device, IDS i10/iSYS/i20 ChLIA systems, EUROLabWorkstation, EUROBlot, and EUROArrayProcessor, plus software platforms (EUROLabOffice, EUROPattern, EUROArrayScan, EUROLabPolaris).

The company serves medical diagnostic laboratories, hospital laboratories, public health institutions, and academic research institutions through a B2B sales-led model executed via 17 wholly-owned country subsidiaries (Germany, France, Italy, Poland, Portugal, Spain, Switzerland, Turkey, UK, Canada, USA, Brazil, Mexico, China, Japan, Singapore, South Africa) plus country representatives and distributors. Revenue is generated through three primary streams: (i) diagnostic reagent kits across IIFT, ELISA, ChLIA, immunoblot, PCR, and microarray — a high-margin consumables business that creates recurring pull-through on installed instruments; (ii) sale and rental of automation equipment (UNIQO 160, IDS i10/i20/iSYS, EUROLabWorkstation, EUROPattern Microscope); and (iii) maintenance, support, and software licensing (EUROPattern, EUROLabOffice, EUROArrayScan, EUROLabPolaris). Pricing is quote-based with no public list, and the offering is anchored on a closed reagent-instrument-software ecosystem protected by CE marking and full IVDR compliance.

With more than 3,500 employees across 17 countries and an installed base including 1,000+ EUROLabOffice deployments, EUROIMMUN positions itself as a mid-to-large international specialty diagnostics platform differentiated primarily by its proprietary BIOCHIP microarray technology, its leadership position in autoimmune and neurology IIFT diagnostics, and its integrated automation ecosystem rather than by AI-native product capabilities. Recent strategic emphasis is on expanding the neurology IIFT menu on UNIQO 160, rolling out the next-generation IDS i20 ChLIA platform, and broadening into dermatology molecular diagnostics via the December 2025 Dermagnostix partnership.

Name

EUROIMMUN Medizinische Labordiagnostika

Legal name

EUROIMMUN Medizinische Labordiagnostika AG

Website

https://euroimmun.de

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

EUROIMMUN Medizinische Labordiagnostika is a German specialty in-vitro diagnostics company and wholly-owned Revvity subsidiary that designs, manufactures, and sells immunological test systems and automation instruments across autoimmunity, infectious disease, allergy, endocrinology, and neurology for clinical laboratories and hospitals in 17 countries.

Ownership category

akta.pro rank

Product category

In-Vitro Medical Laboratory Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLAHAAAA

Clinical Chemistry & Immunoassay Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAHAAAK

Autoimmune, Allergy & Specialized Immunology Diagnostics

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAHAAAN

Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

SECONDARYHLAAALAK

Autoimmune & Allergy Diagnostics

Healthcare & Life Sciences/Biotechnology & Biologics/Diagnostics (Biotech-related)

Keywords

• Medical laboratory diagnostics
• In-vitro diagnostic reagents
• Autoimmune disease testing
• Immunofluorescence assays
• Chemiluminescence immunoassays

Headquarters

HQ city

Lübeck

HQ country

Germany

HQ region

Europe

Offices18 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Test Reagents: Sale of reagent kits for IIFT, ELISA, ChLIA, immunoblot, PCR, and microarray testing across autoimmune, infectious disease, allergy, endocrinology, and neurology diagnostics.
2. Laboratory Automation Equipment: Sale and rental of automation systems including UNIQO 160, IDS i10, IDS iSYS, IDS i20, EUROLabWorkstation, EUROPattern Microscope, and associated software solutions.
3. Maintenance and Support Services: Technical support, device maintenance, software updates, and customer support services for laboratory equipment.
4. Software Licenses: Software solutions including EUROPattern, EUROLabOffice, and EUROArrayScan with associated licensing and updates.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

EUROIMMUN manufactures and sells in-vitro diagnostic test reagents and automation systems for clinical laboratories across seven disease areas: autoimmunity, infectious diseases, allergy, endocrinology, bone metabolism, neurodegeneration, and therapeutic drug monitoring. Its portfolio combines multiple proprietary detection technologies (IIFT, ELISA, ChLIA, Immunoblot, BIOCHIP microarray, Real-Time PCR) with integrated automation instruments (UNIQO 160, IDS i10/iSYS/i20, EUROLabWorkstation, EUROBlot) and laboratory software (EUROLabOffice, EUROPattern, EUROArrayScan). Customers are medical diagnostic laboratories, hospital laboratories, public health institutions, and research institutions served through 17 direct country subsidiaries plus a network of local distributors.

Product overview

EUROIMMUN Medizinische Labordiagnostika is a comprehensive medical diagnostics company offering a broad portfolio of in-vitro diagnostic tests and automation solutions for clinical laboratories. The company operates as a platform-based architecture comprising multiple detection technologies (IIFT, ELISA, ChLIA, Immunoblot, Microarray, Real-Time PCR) organized across diagnostic categories (Autoimmunity, Infectious Diseases, Allergy, Endocrinology, Bone Metabolism, Neurodegeneration, Therapeutic Drug Monitoring). Core instruments include the UNIQO 160 all-in-one IIFT system, IDS i20/i10/iSYS random-access chemiluminescence platforms, EUROLabWorkstation ELISA automation, and supporting software platforms (EUROLabOffice, EUROPattern, EUROArrayScan). The company, a subsidiary of Revvity Inc., is headquartered in Lübeck, Germany with global operations across 17 countries.

Differentiator

Problem solved

Functional benefit

Brands

• EUROArray: Innovative microarray technology for molecular diagnostics
• EURORealTime
• EUROLabWorkstation
• Euroimmun Academy
• Euroimmun Campus
• Euroimmun Blog
• IDS i20
• IDS i10
• IDS-iSYS
• EUROPattern
• UNIQO 160
• EUROLabOffice

Products and services

• IIFT (Indirect Immunofluorescence Tests) Gold-standard indirect immunofluorescence reagent kits and tests for autoantibody detection, particularly in autoimmune and neurology diagnostics. Sold to clinical diagnostic laboratories and run on EUROIMMUN's UNIQO 160 all-in-one IIFT instrument.
• ELISA Reagent Kits Enzyme-linked immunosorbent assay kits for quantitative detection of antibodies and antigens across autoimmunity, infectious disease, allergy, endocrinology, and other diagnostic applications. Processed on automated workstations including EUROLabWorkstation ELISA.
• ChLIA (Chemiluminescence Immunoassay) Reagents Chemiluminescence immunoassay reagent kits for high-sensitivity testing across endocrinology, allergy, autoimmune diseases, infectious diseases, neurodegenerative (Alzheimer's) diagnostics, and therapeutic drug monitoring. Run on IDS i10, IDS-iSYS, and IDS i20 random-access automation systems.
• EUROArray Microarray Diagnostics Microarray-based multiplex diagnostic kits using proprietary BIOCHIPs for molecular diagnostics including EUROArray HPV (30 subtypes) and other genetic/pathogen detection applications. Processed on the EUROArrayProcessor with EUROArrayScan result analysis.
• EURORealTime Real-Time PCR Kits Real-time PCR test kits for direct pathogen detection including respiratory viruses, SARS-CoV-2, and influenza (e.g., EURORealTime SARS-CoV-2/Influenza A/B). Intended for molecular diagnostic laboratories.
• EUROLINE / Immunoblot Tests Line blot and strip-based assays for confirmation and differentiation of antibodies in autoimmune and infectious disease serology, run on EUROBlot automation systems including the EUROBlot and Immunoblot-PreQ.
• UNIQO 160 All-in-One IIFT Instrument All-in-one IIFT automation device that processes multiple indirect immunofluorescence assays simultaneously for neurology and autoimmune diagnostics. Designed to reduce manual workload and increase diagnostic precision through integrated imaging and software. Sold to clinical diagnostic and hospital laboratories.
• IDS i20 Random-Access ChLIA System Random-access chemiluminescence immunoassay automation device with up to 140 tests/hour throughput, continuous sample loading, time to first result under 25 minutes, and walk-away time of more than one day. Handles 20 analytes across six diagnostic areas. Sold to high-throughput clinical laboratories.
• IDS-i10 ChLIA Random-Access System Random-access chemiluminescence immunoassay automation system from the IDS portfolio for clinical diagnostic testing in endocrinology, allergy, autoimmune, infectious disease, and therapeutic drug monitoring applications.
• IDS-iSYS Multi-Discipline ChLIA System Multi-discipline automated chemiluminescence immunoassay system serving as a high-throughput platform in clinical laboratories across the IDS ChLIA portfolio.
• EUROLabWorkstation ELISA Automation Automated ELISA processing workstation for high-throughput clinical diagnostic testing, capable of reducing hands-on time by up to 60% through integrated reagent handling and incubation.
• EUROBlot / EUROBlot One Immunoblot Automation Automated immunoblot processing systems for confirmation and differentiation testing using EUROLINE line blot assays in clinical laboratories.
• EUROArrayProcessor Microarray Automation Automated processing system for BIOCHIP microarray diagnostics including EUROArray HPV testing, paired with EUROArrayScan result analysis.
• EUROPattern Microscope Live (EPML) with EUROLabOffice 4.0 Compact immunofluorescence microscope integrated with EUROLabOffice 4.0 (ELO 4.0) software for on-screen evaluation of IIFT results. Marketed to clinical diagnostic and research laboratories performing autoimmune and infectious disease IIFT.
• EUROLabOffice (ELO) Laboratory Software Platform Laboratory workflow management software platform integrating IIFT, ELISA, ChLIA, immunoblot, microarray, and PCR results for clinical diagnostic laboratories. Reached 1,000 installations milestone. Sold via software license.
• EUROPattern IIFT Image Analysis Software Image capture and pattern interpretation software for indirect immunofluorescence tests in autoimmune diagnostics. Integrated with EUROLabOffice and the EUROPattern Microscope for automated IIFT evaluation. Licensed as a software solution.
• Dried Blood Spots (DBS) Sample Collection Dried blood spot sampling system used for remote antibody collection and simplified logistics in clinical and epidemiological testing (e.g., Anti-Measles Virus ELISA 2.0 usable with dried capillary blood).
• Automated Workstation Pre-NAT II Automated sample preparation workstation for molecular diagnostics, paired with EURORealTime PCR kits for direct pathogen detection workflows.
• EUROArrayScan Microarray Reader Scanner system for microarray slide reading with automated result analysis software for EUROArray diagnostic workflows.
• SARS-CoV-2 NeutraLISA CE-marked surrogate neutralization test (ELISA-based) for determination of neutralizing anti-SARS-CoV-2 antibodies. Sold to clinical and public health laboratories for COVID-19 immunity assessment.
• SARS-CoV-2 Antigen ELISA CE-marked ELISA for specific detection of SARS-CoV-2 protein sold to clinical and public health laboratories for COVID-19 diagnostic testing.
• Maintenance and Technical Support Services Technical support, device maintenance, software updates, and customer support services for EUROIMMUN laboratory equipment and software products. Sold as ongoing service contracts to installed-base customers across 17 countries.

Quantifiable outcome

• Reduction of hands-on time by up to 60% with automated ELISA systems
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Dermagnostix GmbHcoreStrategic or Co-development Partner · 18 December 2025Strategic partnership in molecular diagnostics of skin diseases. Dermagnostix specializes in fully automated plug-and-play molecular diagnostics, and Euroimmun will collaborate on expanding molecular diagnostic offerings in dermatology.
• Immunodiagnostic Systems (IDS)coreStrategic or Co-development Partner · 3 September 2021IDS (Immunodiagnostic Systems Holding) was acquired by PerkinElmer in July 2021 and became part of the Euroimmun portfolio. IDS specializes in chemiluminescence immunoassay (ChLIA) automation systems including IDS i10, IDS iSYS, and IDS i20. The partnership integrates IDS's random-access automation platforms into Euroimmun's diagnostic offerings, expanding capabilities in endocrinology, allergy, autoimmune diseases, infectious diseases, Alzheimer's diagnostics, and therapeutic drug monitoring.
• Oncgnostics GmbHminorChannel Partner/ Reseller/ Distributor · 25 March 2021Distribution partnership for the GynTect cervical cancer test. Oncgnostics develops molecular diagnostics for cervical cancer detection, and Euroimmun handles distribution of the GynTect test through its global network.
• PanadeaminorStrategic or Co-development PartnerPartnership for development and distribution of test systems for the detection of pathogens. Panadea and Euroimmun share the goal of developing and producing molecular diagnostic test systems for pathogen detection.
• Revvity, Inc.coreOthersRevvity, Inc. is the parent company of Euroimmun Medizinische Labordiagnostika AG. Euroimmun operates as a wholly-owned subsidiary of Revvity. Revvity provides centralized ethics hotline and ESG governance framework.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Bio-Rad Laboratories: Bio-Rad is a direct competitor in autoimmune diagnostics and specialty immunoassays, with comparable IIFT, ELISA, and clinical immunology offerings targeting the same hospital and reference laboratory customers as Euroimmun.
• Werfen (Inova Diagnostics): Werfen's Inova Diagnostics division is one of the closest direct peers, specializing in autoimmune diagnostics with BioPlex multiplex and QUANTA Flash chemiluminescence assays that directly overlap Euroimmun's IIFT/ELISA/ChLIA menu.
• Thermo Fisher Scientific (Phadia/Immunodiagnostics): Phadia (Thermo Fisher) is a leader in allergy diagnostics and autoimmune testing, competing with Euroimmun in allergen-specific IgE and autoantibody assay markets served to clinical laboratories.
• DiaSorin: DiaSorin is a specialty IVD manufacturer with strong positions in infectious disease and endocrinology chemiluminescence immunoassays, closely overlapping Euroimmun's IDS-based ChLIA portfolio.

Broad incumbents

• Roche Diagnostics: Roche Diagnostics is a broad-line IVD incumbent with cobas immunoassay analyzers and an extensive autoimmune/infectious disease menu, competing with Euroimmun for hospital laboratory contracts at a much larger scale.
• Abbott Diagnostics: Abbott operates ARCHITECT and Alinity immunoassay platforms covering infectious disease, endocrinology and therapeutic drug monitoring—direct adjacency to Euroimmun's portfolio at significantly larger installed base.
• Siemens Healthineers: Siemens Healthineers' Atellica and ADVIA Centaur immunoassay systems compete with Euroimmun's ChLIA automation in hospital and reference laboratories across routine and specialty diagnostic categories.
• Danaher (Beckman Coulter Diagnostics): Beckman Coulter provides Access/DxI immunoassay analyzers used in hospital laboratories for endocrinology, infectious disease and therapeutic drug monitoring, overlapping Euroimmun's IDS-based ChLIA menu.

Emerging players

• Hologic: Hologic is expanding into molecular diagnostics and women's health, with adjacency to Euroimmun's EURORealTime PCR and EUROArray HPV microarray product lines in pathogen and cervical cancer testing.
• QuidelOrtho: QuidelOrtho is a specialty diagnostics player with immunoassay and molecular offerings (including Sofia, Triage and Vitros) that compete in select infectious disease and specialty testing segments served by Euroimmun.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/EUROIMMUN
• Facebookfacebook.com/EUROIMMUN
• LinkedInlinkedin.com/organization-guest/company/euroimmun
• Instagraminstagram.com/euroimmun
• Xx.com/with_replies

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EUROIMMUN Medizinische Labordiagnostika